COA 2603110039 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Purg2603110039This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
Label 50 mg · Lab measured 47.7 mg
95% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 11.9 mg using the measured mass, against 12.5 mg on the label — 5% less.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 2603110039 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 7 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of GHK-Cu from PurgoLabs peptides, performed by freedomdiagnosticstesting.com on March 12, 2026. Reported purity: 99.527%. Net content: 47.7 mg against 50 mg labeled (95% of label). Batch PL-002. Sample source: shop-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| PL-GHKS-04 | 10 Jul 2026 | freedomdiagnosticstesting.com | 99.82% | 99% | ✓ Lab-verified |
| PL-GHKS-03 | 17 Jun 2026 | freedomdiagnosticstesting.com | 99.33% | 96% | ✓ Lab-verified |
| PL-GHKS-01 | 18 May 2026 | freedomdiagnosticstesting.com | 99.89% | 105% | ✓ Lab-verified |
| PS03-CU02-P | 15 Mar 2026 | freedomdiagnosticstesting.com | 99.455% | 95% | ✓ Lab-verified |
| PS02-GC100 | 1 Feb 2026 | freedomdiagnosticstesting.com | 99.441% | 85% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion